SANUWAVE Health, Inc.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $9.7M | — | $9.6M | — | — | — | $11.3M |
| Cost of Revenue | — | $2.3M | — | $2.2M | — | — | — | $2.5M |
| Gross Profit | — | $7.4M | — | $7.4M | — | — | — | $8.7M |
| Gross Margin | — | 76.2% | — | 77.3% | — | — | — | 77.6% |
| Operating Expenses | ||||||||
| Research & Development | — | $628.0K | — | $660.0K | — | — | — | $345.0K |
| SG&A Expense | — | $4.9M | — | $5.3M | — | — | — | $5.2M |
| Operating Income | — | $-280.0K | — | $-1.1M | — | — | — | $903.0K |
| Operating Margin | — | -2.9% | — | -11.7% | — | — | — | 8.0% |
| Interest Expense | — | $518.0K | — | $546.0K | — | — | — | $1.8M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | $6.0K | — | — | — | — | — | — |
| Net Income | — | $-682.0K | — | $-1.4M | — | — | — | $9.7M |
| Net Margin | — | -7.0% | — | -15.0% | — | — | — | 86.0% |
| EPS (Basic) | — | $-0.08 | — | $-0.17 | — | — | — | $0.57 |
| EPS (Diluted) | — | $-0.08 | — | $-0.17 | — | — | — | $0.20 |
| Shares Outstanding (Basic) | 8.6M | 8.6M | 8.6M | 8.6M | 8.6M | 8.6M | 17.2M | 17.1M |
| Shares Outstanding (Diluted) | 8.6M | 8.6M | 8.6M | 8.6M | 8.6M | 8.6M | 17.2M | 18.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |